Importance of evaluation of heart-type fatty acid binding protein (H-FABP) in COVID-19 Patients

• Published in: Journal of infection in developing countries Vol. 18; no. 2; pp. 172 - 176
• Main Authors: Ordekci, Seyhan, Tekin Neijmann, Sebnem
• Format: Journal Article
• Language: English
• Published: Italy 29.02.2024
• Subjects: Biomarkers; COVID-19 - diagnosis; Creatine Kinase, MB Form; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Humans; Myocardial Infarction - diagnosis; Sensitivity and Specificity; COVID-19; H-FABP; acute cardiac injury
• ISSN: 1972-2680; 1972-2680
• DOI: 10.3855/jidc.17419

Recent studies have documented the cardiovascular consequences of acute coronavirus disease 2019 (COVID-19), although one of the early cardiac markers that can be used for diagnosis, the heart-type fatty acid-binding protein (H-FABP), has not been covered. Through the evaluation of H-FABP levels, we aim to contribute to the early diagnosis and treatment of cardiac problems in COVID-19 infection patients. Seventy-five patients who were admitted to the emergency department of Mehmet Akif Ersoy Hospital with a complaint of chest pain in the last 6 hours and whose corona PCR tests were positive, were included in our study as the case group and 60 healthy volunteers as the control group. The routine cardiac markers such as creatine kinase MB (CK-MB) cardiac troponin T (cTnT), and H-FABP levels were analyzed by routine laboratory methods. The mean age and gender distributions of the groups did not differ statistically (p > 0.05). CK-MB, cTnT, and H-FABP measurements were statistically different between the groups (p = 0.001; p < 0.01). The relationship between AMI and COVID-19 with routine cardiac markers is already supported by recent studies. We also evaluated H-FABP levels in our study, as it affects the prognosis of the disease independent of the chronic disease history. At the same time, we showed that H-FABP levels increase earlier than routine cardiac markers, so it will be useful for COVID-19 patients with cardiac complaints.